Reliv International Inc. is taking over the production of its award-winning LunaRich X supplement with the installation of an in-house encapsulation line.
The addition to Reliv’s St. Louis-area headquarters will enable the nutrition brand to meet increasing demand and ensure quality control, said Chief Operating Officer Brett Hastings. “We can now manufacture more than 48,000 capsules per hour to support the growing businesses of Reliv distributors around the world,” Hastings shared in the company’s release. “The line will also keep costs low and pave the way for future encapsulated product offerings.”
LunaRich X is the company’s powerhouse lunasin supplement. Lunasin, a naturally occurring soy peptide, has been the subject of more than 80 published papers from dozens of research institutions. A University of Missouri study showed that Reliv’s LunaRich X supplement aids in promoting metabolic health. The product was named 2013 People’s Choice for Favorite New Consumer Product by the American Business Awards.
Reliv generated revenue of $57.3 million in 2014, down 20 percent from 2013. Following losses in the first half of the year, the company posted profit in the third and fourth quarters as changes to its compensation plan and a cost containment initiative took effect. Net income was $725,000 versus $777,000 in 2013, with earnings remaining steady at 6 cents per share.